ORIGINAL PAPER
Lifestyle and health of individuals with multiple sclerosis according to body mass index: initial results
1
Collegium Medicum, Jan Kochanowski University, Kielce, Poland Head of the Collegium: Prof. Marianna Janion MD, PhD
2
Resmedica, Kielce
Submission date: 2022-02-23
Final revision date: 2022-06-21
Acceptance date: 2022-06-22
Publication date: 2022-06-30
Medical Studies 2022;38(2):140-151
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Increased body mass index (BMI) correlates with an increased risk of many diseases and is thought to be a risk factor in multiple sclerosis (MS).
Aim of the research:
To assess the lifestyle and health of adult individuals with MS, according to their relative BMI.
Material and methods:
The study participants comprised 115 individuals with MS. The participants underwent anthropometric measurements, functional tests, lifestyle assessments, and a biochemical blood parameter analysis that included the fasting glucose, triglyceride, HDL-cholesterol, vitamin D, and biotin concentrations.
Results:
In total, 40.9% of the participants were overweight or obese. The compared groups did not differ significantly in terms of the degree of their physical disability. The overweight group showed a higher functional ability of the lower limbs than the underweight group. Conversely, the underweight and the normal-weight group showed a higher relative hand grip strength than individuals with overweight and obesity (p < 0.05). Metabolic syndrome was more prevalent in the overweight and obese participants (p < 0.05). The obese individuals drank sweetened carbonated or still drinks significantly more often than the other individuals. They also consumed potatoes more often and other vegetables less often than the other participants (p < 0.05).
Conclusions:
Individuals with MS differed in terms of the values of their metabolic parameters, functional ability of the lower limbs, and relative hand grip strength, depending on their BMI. The occurrence of obesity may have resulted, at least partially, from differences in diet and physical activity.
Increased body mass index (BMI) correlates with an increased risk of many diseases and is thought to be a risk factor in multiple sclerosis (MS).
Aim of the research:
To assess the lifestyle and health of adult individuals with MS, according to their relative BMI.
Material and methods:
The study participants comprised 115 individuals with MS. The participants underwent anthropometric measurements, functional tests, lifestyle assessments, and a biochemical blood parameter analysis that included the fasting glucose, triglyceride, HDL-cholesterol, vitamin D, and biotin concentrations.
Results:
In total, 40.9% of the participants were overweight or obese. The compared groups did not differ significantly in terms of the degree of their physical disability. The overweight group showed a higher functional ability of the lower limbs than the underweight group. Conversely, the underweight and the normal-weight group showed a higher relative hand grip strength than individuals with overweight and obesity (p < 0.05). Metabolic syndrome was more prevalent in the overweight and obese participants (p < 0.05). The obese individuals drank sweetened carbonated or still drinks significantly more often than the other individuals. They also consumed potatoes more often and other vegetables less often than the other participants (p < 0.05).
Conclusions:
Individuals with MS differed in terms of the values of their metabolic parameters, functional ability of the lower limbs, and relative hand grip strength, depending on their BMI. The occurrence of obesity may have resulted, at least partially, from differences in diet and physical activity.
REFERENCES (42)
2.
Kapica-Topczewska K, Brola W, Fudala M, Tarasiuk J, Chorazy M, Snarska K, Kochanowicz J, Kulakowska A. Prevalence of multiple sclerosis in Poland. Mult Scler Relat Disord 2018; 21: 51-55.
3.
Olsson T, Barcellos LF, Alfredsson L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol 2017; 13: 25-36.
4.
Global BMI Mortality Collaboration, Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, Berrington de Gonzalez A, Cairns BJ, Huxley R, Jackson ChL, Joshy G, Lewington S, Manson JE, Murphy N, Patel AV, Samet JM, Woodward M, Zheng W, Zhou M, Bansal N, Barricarte A, Carter B, Cerhan JR, Smith GD, Fang X, Franco OH, Green J, Halsey J, Hildebrand JS, Jung KJ, Korda RJ, McLerran DF, Moore SC, O’Keeffe LM, Paige E, Ramond A, Reeves GK, Rolland B, Sacerdote C, Sattar N, Sofianopoulou E, Stevens J, Thun M, Ueshima H, Yang L, Yun YD, Willeit P, Banks E, Beral V, Chen Zh, Gapstur SM, Gunter MJ, Hartge P, Jee SH, Lam TH, Peto R, Potter JD, Willett WC, Thompson SG, Danesh J, Hu FB. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet 2016; 388: 776-786.
5.
Larsson SC, Burgess S. Causal role of high body mass index in multiple chronic diseases: a systematic review and meta-analysis of mendelian randomization studies. BMC Med 2021; 19: 320.
6.
Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev 2014; 13: 981-1000.
7.
Mokry LE, Ross S, Timpson NJ, Sawcer S, Davey Smith G, Richards JB. Obesity and multiple sclerosis: a mendelian randomization study. PLoS Med 2016; 13: e1002053.
8.
Hedstrom AK, Olsson T, Alfredsson L. Body mass index during adolescence, rather than childhood, is critical in determining MS risk. Mult Scler 2016; 22: 878-883.
9.
Emamgholipour S, Eshaghi SM, Hossein-Nezhad A, Mirzaei K, Maghbooli Z, Sahraian MA. Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease. PLoS One 2013; 8: e76555.
10.
Schreiner TG, Genes TM. Obesity and multiple sclerosis – a multifaceted association. J Clin Med 2021; 10: 2689.
11.
Rijnsburger M, Djuric N, Mulder IA, de Vries HE. Adipokines as immune cell modulators in multiple sclerosis. Int J Mol Sci 2021; 22: 10845.
12.
Mokry LE, Ross S, Ahmad OS, Forgetta V, Smith GD, Goltzman D, Leong A. Greenwood CM, Thanassoulis G, Richards JB. Vitamin D and risk of multiple sclerosis: a mendelian randomization study. PLoS Med 2015; 12: e1001866.
13.
Walsh JS, Bowles S, Evans AL. Vitamin D in obesity. Curr Opin Endocrinol Diabetes Obes 2017; 24: 389-394.
14.
Jagannath VA, Filippini G, Di Pietrantonj C, Asokan GV, Robak EW, Whamond L, Robinson SA. Vitamin D for the management of multiple sclerosis. Cochrane Database Syst Rev 2018; 9: CD008422.
15.
Marck CH, Neate SL, Taylor KL, Weiland TJ, Jelinek GA. Prevalence of comorbidities, overweight and obesity in an international sample of people with multiple sclerosis and associations with modifiable lifestyle factors. PLoS One 2016; 11: e0148573.
16.
Pinhas-Hamiel O, Livne M, Harari G, Achiron A. Prevalence of overweight, obesity and metabolic syndrome components in multiple sclerosis patients with significant disability. Eur J Neurol 2015; 9: 1275-1279.
17.
Koch MW, Mostert JP, Wolinsky JS, Lublin FD, Uitdehaag B, Cutter GR. Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg test as clinical prial outcomes in relapsing-remitting multiple sclerosis. Neurology 2021; 97: e1560-e1570.
18.
Kowalkowska J, Wądolowska L, Czarnocinska J, Czlapka-Matyasik M, Galinski G, Jeżewska-Zychowicz M, Bronkowska M, Długosz A, Łoboda D, Wyka J. Reproducibility of a questionnaire for dietary habits, lifestyle and nutrition knowledge assessment (KomPAN) in Polish adolescents and adults. Nutrients 2018; 10: 1845.
19.
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
20.
Martin BW, Kahlmeier S, Racioppi F, Berggren F, Miettinen M, Oppert JM. Evidence-based physical activity promotion – HEPA Europe, the european network for the promotion of health-enhancing physical activity. J Public Health 2006; 14: 53-57.
21.
Breda J, Jakovljevic J, Rathmes G, Mendes R, Fontaine O, Hollmann S, Rütten A, Gelius P, Kahlmeier S, Galea G. Promoting health-enhancing physical activity in Europe: current state of surveillance, policy development and implementation. Health Policy 2018; 122: 519-527.
22.
Stepaniak U, Micek A, Waśkiewicz A, Bielecki W, Drygas W, Janion M, Kozakiewicz K, Niklas A, Puch-Walczak A, Pa- jąk A. Prevalence of general and abdominal obesity and overweight among adults in Poland. Results of the WOBASZ II study (2013-2014) and comparison with the WOBASZ study (2003-2005). Pol Arch Med Wewn 2016; 126: 662-671.
23.
Dardiotis E, Tsouris Z, Aslanidou P, Aloizou AM, Sokratous M, Provatas A, Siokas V, Deretzi G, Hadjigeorgiou GM. Body mass index in patients with multiple sclerosis: a meta-analysis. Neurol Res 2019; 41: 836-846.
24.
Bove R, Musallam A, Xia Z, Baruch N, Messina S, Healy BC, Chitnis T. Longitudinal BMI trajectories in multiple sclerosis: sex differences in association with disease severity. Mult Scler Relat Disord 2016; 8: 136-140.
25.
Markianos M, Evangelopoulos ME, Koutsis G, Davaki P, Sfagos C. Body mass index in multiple sclerosis: associations with CSF neurotransmitter metabolite levels. ISRN Neurol 2013; 2013: 981070.
26.
Degenhardt A, Ramagopalan SV, Scalfari A, Ebers GC. Clinical prognostic factors in multiple sclerosis: a natural history review. Nat Rev Neurol 2009; 5: 672-682.
27.
Siokas V, Katsiardanis K, Aloizou AM, Bakirtzis C, Liampas I, Koutlas E, Rudolf J, Ntinoulis K, Kountouras J, Dardiotis E, Deretzi G. Impact of body mass index on the age of relapsing-remitting multiple sclerosis onset: a retrospective study. Neurol Int 2021; 13: 517-526.
28.
Ten Hoor GA, Plasqui G, Schols AMWJ, Kok G. A benefit of being heavier is being strong: a cross-sectional study in young adults. Sports Med Open 2018; 4: 12.
29.
Vrettos I, Voukelatou P, Pappa E, Beletsioti C, Papadopou- los A, Niakas D. Increased body mass index and hypertension: an unbreakable bond. Int J Prev Med 2020; 11: 155.
30.
Fisher E, Brzezinski RY, Ehrenwald M, Shapira I, Zeltser D, Berliner S, Marcus Y, Shefer G, Stern N, Rogowski O, Halperin E, Rosset S, Shenhar-Tsarfaty S. Increase of body mass index and waist circumference predicts development of metabolic syndrome criteria in apparently healthy individuals with 2 and 5 years follow-up. Int J Obes 2019; 43: 800-807.
31.
Sicras-Mainar A, Ruíz-Beato E, Navarro-Artieda R, Maurino J. Comorbidity and metabolic syndrome in patients with multiple sclerosis from Asturias and Catalonia, Spain. BMC Neurol 2017; 17: 134.
32.
Hauer L, Perneczky J, Sellner J. A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications. J Neurol 2021; 268: 4066-4077.
33.
Walawska-Hrycek A, Galus W, Hrycek E, Kaczmarczyk A, Krzystanek E. The impact of vitamin D low doses on its serum level and cytokine profile in multiple sclerosis patients. J Clin Med 2021; 10: 2781.
34.
Szymczak-Pajor I, Miazek K, Selmi A, Balcerczyk A, Śliwińska A. The action of vitamin D in adipose tissue: is there the link between vitamin D deficiency and adipose tissue-related metabolic disorders? Int J Mol Sci 2022; 23: 956.
35.
McCarty MF, DiNicolantonio JJ. Neuroprotective potential of high-dose biotin. Med Hypotheses 2017; 109: 145-149.
36.
Demas A, Cochin JP, Hardy C, Vaschalde Y, Bourre B, Labauge P. Tardive reactivation of progressive multiple sclerosis during treatment with biotin. Neurol Ther 2020; 9: 181-185.
37.
Jeżewska-Zychowicz M, Gębski J, Plichta M, Guzek D, Kosicka-Gębska M. Diet-related factors, physical activity, and weight status in polish adults. Nutrients 2019; 11: 2532.
38.
Suliga E, Kozieł D, Cieśla E, Rębak D, Głuszek S. Dietary patterns in relation to metabolic syndrome among adults in Poland: a cross-sectional study. Nutrients 2017; 9: 1366.
39.
Suliga E, Kozieł D, Cieśla E, Rębak D, Głuszek S. Coffee consumption and the occurrence and intensity of metabolic syndrome: a cross-sectional study. Int J Food Sci Nutr 2017; 68: 507-513.
40.
Grosso G, Stepaniak U, Micek A, Topor-Madry R, Pik- hart H, Szafraniec K, Pajak A. Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study. Eur J Nutr 2015; 54: 1129-1137.
41.
Yamagata K. Do coffee polyphenols have a preventive action on metabolic syndrome associated endothelial dysfunctions? An assessment of the current evidence. Antioxidants 2018; 7: 26.
42.
Hedstrom AK, Mowry EM, Gianfrancesco MA, Shao X, Schaefer CA, Shen L, Olsson T, Barcellos LF, Alfredsson L. High consumption of coffee is associated with decreased multiple sclerosis risk: results from two independent studies. J Neurol Neurosurg Psychiatry 2016; 87: 454-460.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
